PT3820856T - Compostos de c-manosídeo úteis para o tratamento de infeções do trato urinário - Google Patents

Compostos de c-manosídeo úteis para o tratamento de infeções do trato urinário

Info

Publication number
PT3820856T
PT3820856T PT197692205T PT19769220T PT3820856T PT 3820856 T PT3820856 T PT 3820856T PT 197692205 T PT197692205 T PT 197692205T PT 19769220 T PT19769220 T PT 19769220T PT 3820856 T PT3820856 T PT 3820856T
Authority
PT
Portugal
Prior art keywords
treatment
urinary tract
compounds useful
tract infections
mannoside compounds
Prior art date
Application number
PT197692205T
Other languages
English (en)
Original Assignee
Glaxosmithkline Ip Dev Ltd
Fimbrion Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Ip Dev Ltd, Fimbrion Therapeutics Inc filed Critical Glaxosmithkline Ip Dev Ltd
Publication of PT3820856T publication Critical patent/PT3820856T/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • C07H7/04—Carbocyclic radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT197692205T 2018-07-10 2019-07-08 Compostos de c-manosídeo úteis para o tratamento de infeções do trato urinário PT3820856T (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862695993P 2018-07-10 2018-07-10
US201862755588P 2018-11-05 2018-11-05

Publications (1)

Publication Number Publication Date
PT3820856T true PT3820856T (pt) 2022-10-17

Family

ID=67957191

Family Applications (1)

Application Number Title Priority Date Filing Date
PT197692205T PT3820856T (pt) 2018-07-10 2019-07-08 Compostos de c-manosídeo úteis para o tratamento de infeções do trato urinário

Country Status (24)

Country Link
US (3) US11111262B2 (pt)
EP (1) EP3820856B9 (pt)
JP (2) JP7309862B2 (pt)
KR (1) KR20210031682A (pt)
CN (1) CN112334455B (pt)
AU (1) AU2019301946B2 (pt)
BR (1) BR112021000370A2 (pt)
CA (1) CA3105940A1 (pt)
CL (1) CL2021000033A1 (pt)
DK (1) DK3820856T3 (pt)
ES (1) ES2928634T3 (pt)
HR (1) HRP20221381T1 (pt)
HU (1) HUE060140T2 (pt)
IL (1) IL279993B2 (pt)
LT (1) LT3820856T (pt)
MX (1) MX2021000340A (pt)
PH (1) PH12020551905A1 (pt)
PL (1) PL3820856T3 (pt)
PT (1) PT3820856T (pt)
RS (1) RS63712B1 (pt)
SG (1) SG11202011066XA (pt)
TW (1) TWI821328B (pt)
UY (1) UY38293A (pt)
WO (1) WO2020012336A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210031682A (ko) 2018-07-10 2021-03-22 글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 요로 감염의 치료에 유용한 c-만노시드 화합물
KR20220002890A (ko) 2019-03-19 2022-01-07 뵈링거 잉겔하임 애니멀 헬스 유에스에이 인코포레이티드 구충성 아자-벤조티오펜 및 아자-벤조푸란 화합물
WO2021197363A1 (zh) * 2020-03-31 2021-10-07 苏州大学 2-炔基甘露糖衍生物及其应用
KR20230028268A (ko) 2020-05-29 2023-02-28 뵈링거 잉겔하임 애니멀 헬스 유에스에이 인코포레이티드 구충성 헤테로시클릭 화합물

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5122602A (en) 1989-02-13 1992-06-16 Miles Inc. Chromogenic merocyanine enzyme substrates
US6420127B1 (en) 1994-11-18 2002-07-16 Washington University Compounds and pharmaceutical compositions for the treatment and prophylaxis of bacterial infections
CA2176808A1 (en) 1993-11-18 1995-05-26 Scott Hultgren Compounds and pharmaceutical compositions for the treatment and prophylaxis of bacterial infections
ATE253444T1 (de) 1999-06-28 2003-11-15 Lear Corp Verfahren zum formen eines blasgeformten kunststoffteils mit filmscharnier
AU7470300A (en) 1999-08-11 2001-03-05 Washington University Anti-bacterial compounds directed against pilus biogenesis, adhesion and activity; co-crystals of pilus subunits and methods of use thereof
ATE419880T1 (de) 2000-06-09 2009-01-15 Baylor College Medicine Kombination von antimikrobiellen wirkstoffen und bakterieller interferenz zum überziehen medizinischer vorrichtungen
WO2005033059A1 (es) 2003-10-08 2005-04-14 Innovaprotean, S.L. Compuestos útiles para el tratamiento de enfermedades asociadas a la formación de fibrilas amiloides
WO2005089733A2 (en) 2004-03-23 2005-09-29 Vib Vzw Anti-adhesive compounds to prevent and treat bacterial infections
SE528382C2 (sv) 2004-10-05 2006-10-31 Probi Ab Probiotiska lactobacillusstammar för förbättrad vaginal hälsa
FR2876798A1 (fr) 2004-10-14 2006-04-21 Univ Clermont Auvergne Diagnostic et traitement de la maladie de crohn
EP2490530A4 (en) 2009-10-22 2014-01-22 Univ Washington COMPOUNDS AND METHOD FOR THE TREATMENT OF BACTERIAL INFECTIONS
EP2604619A3 (en) 2009-12-14 2014-01-22 University of Basel Mannose derivatives as antagonists of bacterial adhesion
EP2672820B1 (en) 2011-02-07 2019-04-17 The Washington University Mannoside compounds and methods of use thereof
WO2012164074A1 (en) 2011-06-03 2012-12-06 University Of Basel Mannose phosphate derivatives as antagonists of bacterial adhesion
CA2869416A1 (en) 2012-03-07 2013-09-12 Vertex Pharmaceuticals Incorporated Mannose derivatives for treating bacterial infections
EP2690105A1 (en) 2012-07-24 2014-01-29 Centre National De La Recherche Scientifique Mannose derivatives, a process for preparing the same and their uses as a drug
US20140107049A1 (en) 2012-10-04 2014-04-17 Vertex Pharmaceuticals Incorporated Mannose derivatives for treating bacterial infections
CA2894536C (en) 2012-12-18 2020-07-28 Vertex Pharmaceuticals Incorporated Mannose derivatives for treating bacterial infections
EP2970353B1 (en) 2013-03-12 2018-04-18 Vertex Pharmaceuticals Incorporated Mannose derivatives for treating bacterial infections
AU2014273962B2 (en) 2013-05-30 2019-07-25 Washington University Compounds and methods for treating bacterial infections
WO2017021549A1 (en) 2015-08-05 2017-02-09 Enterome Mannose derivatives useful for treating pathologies associated with adherent e. coli
US20200002303A1 (en) 2016-03-11 2020-01-02 Fimbrion Therapeutics, Inc. C-glycoside compounds useful for treating disease
US10738070B2 (en) 2016-03-23 2020-08-11 Fimbrion Therapeutics, Inc. Mannose-derived antagonists of FimH useful for treating disease
CA3079119A1 (en) 2017-10-16 2019-04-25 Enterome New tools for assessing fimh blockers therapeutic efficiency
KR20210031682A (ko) 2018-07-10 2021-03-22 글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 요로 감염의 치료에 유용한 c-만노시드 화합물

Also Published As

Publication number Publication date
BR112021000370A2 (pt) 2021-04-06
JP2022191325A (ja) 2022-12-27
ES2928634T3 (es) 2022-11-21
US20210017212A1 (en) 2021-01-21
DK3820856T3 (da) 2022-10-24
CL2021000033A1 (es) 2021-07-30
IL279993B1 (en) 2023-09-01
CN112334455A (zh) 2021-02-05
HRP20221381T1 (hr) 2023-01-06
EP3820856B1 (en) 2022-08-31
JP7483820B2 (ja) 2024-05-15
LT3820856T (lt) 2022-11-10
AU2019301946A1 (en) 2020-11-26
IL279993A (en) 2021-03-01
TW202019893A (zh) 2020-06-01
HUE060140T2 (hu) 2023-02-28
CN112334455B (zh) 2022-07-01
AU2019301946B2 (en) 2022-03-31
MX2021000340A (es) 2021-03-25
PL3820856T3 (pl) 2022-12-19
US20230287028A1 (en) 2023-09-14
EP3820856B9 (en) 2023-07-12
UY38293A (es) 2020-05-29
WO2020012336A1 (en) 2020-01-16
SG11202011066XA (en) 2021-01-28
JP7309862B2 (ja) 2023-07-18
TWI821328B (zh) 2023-11-11
IL279993B2 (en) 2024-01-01
CA3105940A1 (en) 2020-01-16
US11111262B2 (en) 2021-09-07
JP2022511594A (ja) 2022-02-01
RS63712B1 (sr) 2022-11-30
US20210395287A1 (en) 2021-12-23
EP3820856A1 (en) 2021-05-19
US11697665B2 (en) 2023-07-11
PH12020551905A1 (en) 2021-06-21
KR20210031682A (ko) 2021-03-22

Similar Documents

Publication Publication Date Title
IL272766A (en) A nesting pump to increase the removal of urine from the urinary tract
IL279993B1 (en) Mannoside-c compounds are useful for treating urinary tract infections
ZA202001721B (en) Chromane monobactam compounds for the treatment of bacterial infections
IL279260A (en) KDM1A inhibitors for the treatment of diseases
IL271863B (en) Compounds and their use for the treatment of microbial infections
IL276482A (en) Compounds for pain management
IL250596A0 (en) The composition for the treatment and prevention of urinary tract infections
IL271236A (en) Licofligozin for the treatment of non-alcoholic steatohepatitis
EP3709968C0 (de) Emulsionen zur behandlung von schleimhautinfektionen
EP4121403A4 (en) NITRO-AMINOADAMANTANE COMPOUNDS FOR THE TREATMENT OF BETACORONAVIRUS INFECTIONS
IL276413A (en) A device for the treatment of urinary tract infections
EP3866601A4 (en) ORGANOSILANES TO TREAT AN INFECTION
IL258683A (en) Gel-based compositions for treating urinary tract infections
GB2591598B (en) Composition for the treatment of urinary tract infections
EP3604310A4 (en) CDC-7 INHIBITOR COMPOUNDS AND USE THEREOF IN THE TREATMENT OF NEUROLOGICAL DISEASES
SG10201405850PA (en) Composition for prevention or treatment of urinary tract infection
GB201911728D0 (en) Bacterial composistions for the treatment of disease
ZA201901948B (en) Heteroaryltrifluoroborate compounds for the treatment of mycobacterial infections
GB201813721D0 (en) Treatment of urinary tract disorders
EP3890731A4 (en) COMPOUNDS FOR THE TREATMENT OF ARENAVIRUS INFECTION
EP3773221A4 (en) TREATMENT OF HYDROCEPHALUS
GB201820529D0 (en) Compounds and combinations for the treatment of rosacea
GB201714014D0 (en) Treatment of urinary tract disorders
ZA201705781B (en) Pharmaceutical compositions for the treatment of bacterial infections
AU2017902918A0 (en) Treatment of infections (1)